PEPTIDE IMMUNISANT, PROCEDE DE FABRICATION DU PEPTIDE IMMUNISANT, COMPOSITION PHARMACEUTIQUE CONTENANT CELUI-CI ET CIBLANT LES TROUBLES DE L'IMMUNITE, ET METHODE DE TRAITEMENT DE TROUBLES DE L'IMMUNITE
Provided is a novel immunizing peptide with which it is possible to induce antibody production to complexes that include the immunizing peptide and the MHC molecule of a living body. The immunizing peptide of the present invention is characterized in that: the immunizing peptide includes a T-cell epitope and antibody induction portion of a target protein； the antibody induction portion comprises one or more consecutive amino acids sequences upstream from the N-end amino acid of the T-cell epitope, and/or one or more consecutive amino acids sequences downstream from the C-end amino acid of the T-cell epitope, in the amino acid sequence of the target protein； and, when administered to a living body, the immunizing peptide induces antibody production to complexes that include the immunizing peptide and the MHC molecule of the living body.
